Algert Global LLC Fate Therapeutics Inc Transaction History

Algert Global LLC

  • $4.25 Billion
  • Q4 2024

A detailed history of Algert Global LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Algert Global LLC holds 65,510 shares of FATE stock, worth $59,614. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,510
Previous 65,611 0.15%
Holding current value
$59,614
Previous $230,000 53.04%
% of portfolio
0.0%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$1.61 - $3.35 $162 - $338
-101 Reduced 0.15%
65,510 $108,000
Q2 2024

Aug 14, 2024
BUY
$3.26 - $7.08 $162,775 - $353,511
49,931 Added 318.44%
65,611 $215,000
Q1 2024

May 14, 2024
SELL
$3.54 - $8.35 $230,007 - $542,532
-64,974 Reduced 80.56%
15,680 $115,000
Q4 2023

Feb 14, 2024
SELL
$1.65 - $3.94 $18,496 - $44,167
-11,210 Reduced 12.2%
80,654 $302,000
Q3 2023

Nov 13, 2023
SELL
$2.02 - $5.04 $898,833 - $2.24 Million
-444,967 Reduced 82.89%
91,864 $195,000
Q2 2023

Aug 14, 2023
BUY
$4.76 - $6.59 $743,959 - $1.03 Million
156,294 Added 41.07%
536,831 $2.56 Million
Q1 2023

May 12, 2023
BUY
$4.24 - $11.12 $1.61 Million - $4.23 Million
380,537 New
380,537 $2.17 Million
Q2 2022

Aug 15, 2022
SELL
$17.78 - $42.39 $379,709 - $905,280
-21,356 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$29.67 - $60.28 $363,309 - $738,128
12,245 Added 134.4%
21,356 $828,000
Q4 2021

Feb 14, 2022
BUY
$47.84 - $64.34 $56,929 - $76,564
1,190 Added 15.02%
9,111 $533,000
Q3 2021

Nov 15, 2021
BUY
$59.27 - $95.73 $469,477 - $758,277
7,921 New
7,921 $469,000
Q2 2018

Aug 02, 2018
SELL
$9.16 - $13.48 $161,032 - $236,978
-17,580 Closed
0 $0
Q1 2018

May 03, 2018
BUY
$6.3 - $13.77 $110,754 - $242,076
17,580 New
17,580 $172,000
Q4 2017

Feb 01, 2018
SELL
$3.94 - $6.64 $278,467 - $469,295
-70,677 Closed
0 $0
Q3 2017

Nov 17, 2017
BUY
$2.6 - $4.31 $183,760 - $304,617
70,677
70,677 $280,000

Others Institutions Holding FATE

# of Institutions
167
Shares Held
101M
Call Options Held
41.3K
Put Options Held
15.9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $88.3M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email